Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. HGHAX: which is better?

Bottom line

XLV vs HGHAX: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and HGHAX (The Hartford Healthcare Fund) share a meaningful slice of their top holdings — about 72% by weight.

XLV is cheaper at 0.08% vs 1.33% — a difference of $125 a year per $10,000 invested.

HGHAX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

XLV vs HGHAX side by side

XLVHGHAX
TypeETFMutual fund
Fund familySPDR (State Street)Hartford
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%1.33%
Annual cost per $10k$8$133
10-yr cost on $10k (prospectus)$103$2,063
Max front loadNone5.5%
12b-1 fee0.02%0.25%
1-yr return+14.5%—
5-yr return (annualized)+8.1%—
10-yr return (annualized)+9.8%—
Best quarter+14.5%+20.9%
Worst quarter−12.7%−15.7%
Net assets (fund)$40.6B$772.2M
Number of holdings6580
Portfolio turnover2%49%
Returns as ofDec 31, 2025—

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVHGHAXDifference
2025+14.5%+15.6%−1.1%
2024+2.5%0.0%+2.5%
2023+2.0%+3.8%−1.8%
2022−2.1%−11.7%+9.7%
2021+25.9%+10.0%+16.0%
2020+13.3%+22.6%−9.3%
2019+20.7%+33.3%−12.6%
2018+6.3%−3.0%+9.3%
2017+21.7%+21.6%+0.1%
2016−2.8%−8.6%+5.7%

Source: Fund prospectus bar charts

Holdings overlap

19 of XLV's top 25 holdings also appear in HGHAX's top 25.

Shared top holdings
HoldingXLVHGHAX
Eli Lilly & Co16.51%12.03%
Johnson & Johnson10.64%6.75%
AbbVie Inc7.74%4.21%
UnitedHealth Group Inc6.57%4.74%
Merck & Co Inc5.52%6.00%
Amgen Inc3.40%1.39%
Thermo Fisher Scientific Inc3.24%1.58%
Abbott Laboratories2.75%1.82%
Intuitive Surgical Inc2.45%2.88%
CVS Health Corp2.30%2.84%
Vertex Pharmaceuticals Inc2.19%2.64%
Danaher Corp2.09%2.57%
Stryker Corp1.89%1.24%
Medtronic PLC1.75%1.12%
Elevance Health Inc1.46%3.00%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

HGHAX top 10

  1. Eli Lilly & Co — 12.03%
  2. Johnson & Johnson — 6.75%
  3. Merck & Co Inc — 6.00%
  4. UnitedHealth Group Inc — 4.74%
  5. AbbVie Inc — 4.21%
  6. Elevance Health Inc — 3.00%
  7. Intuitive Surgical Inc — 2.88%
  8. CVS Health Corp — 2.84%
  9. Vertex Pharmaceuticals Inc — 2.64%
  10. Danaher Corp — 2.57%

FAQ

What is the difference between XLV and HGHAX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and HGHAX (The Hartford Healthcare Fund) share a meaningful slice of their top holdings — about 72% by weight. XLV is cheaper at 0.08% vs 1.33% — a difference of $125 a year per $10,000 invested.
Which is cheaper, XLV or HGHAX?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and HGHAX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.